Senator Mike Lee Urges Action for Transitional Coverage of Innovative Med Tech
October 13, 2022
Senator Mike Lee (R-UT) and a group of like-minded colleagues are preparing to send a letter to CMS Administration Chiquita Brooks-LaSure urging the agency to issue a proposed rule by year’s end to provide accelerated Medicare coverage for emerging medical technologies. Medicare patients should have timely access to innovative and beneficial care, which can change lives and improve patient outcomes.
After repealing the “Medicare Coverage for Innovative Technology” (MCIT) rule last year, CMS has expressed interest in creating a transitional coverage pathway, termed “Transitional Coverage for Emerging Technologies” or TCET. However, to date, a new round of rulemaking has not materialized.
During a day in the BioHive in August, Lee toured a number of Utah life sciences companies who expressed concerns about the unpredictable and lengthy process to obtain Medicare coverage and reimbursement.
“BioUtah thanks Senator Lee for recognizing the need to develop policy that gives seniors quicker access to the most cutting-edge and effectve technologies possible,” said Kelvyn Cullimore, president and CEO of BioUtah.
The Senate letter, once finalized, is expected to be shared with CMS in a matter of days.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
